Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-23-001086
Filing Date
2023-01-31
Accepted
2023-01-31 15:08:52
Documents
2
Period of Report
2023-01-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1411
2 POWER OF ATTORNEY marcelruegg-poa.htm EX-24 6593
  Complete submission text file 0001654954-23-001086.txt   9643
Mailing Address EUROPEAN EXECUTIVE OFFICE 4, ROUTE DE LA CORNICHE EPALINGES V8 CH-1066
Business Address EUROPEAN EXECUTIVE OFFICE 4, ROUTE DE LA CORNICHE EPALINGES V8 CH-1066 011-41-21-653-45-35
MYMETICS CORP (Issuer) CIK: 0000927761 (see all company filings)

EIN.: 251741849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MYMETICS CORPORATION ROUTE DE LA CORNICHE 4 1066 EPALINGES V8 NA
Business Address
Ruegg Marcel B. (Reporting) CIK: 0001963425 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25132 | Film No.: 23572211